Rare EGFR Mutation Shows Primary Resistance to Afatinib in Lung Cancer Case
A case report documents rapid progression and death in a lung cancer patient with a rare EGFR PACC mutation who showed primary resistance to afatinib.
A case report documents rapid progression and death in a lung cancer patient with a rare EGFR PACC mutation who showed primary resistance to afatinib.
by Neoklis Makrides, Emily Sun, Hilal Mir, Jen-Zen Chuang, Ziyuan Jiang, Yihua Wu, Carlos Serra, John Peregrin, Qian Wang, Wellington V. Cardoso, Ching-Hwa Sung, Neel H. Shah, Xin...
The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic targeting of p53, the most commonly altered gene in human cance...
by Michael D. Nicholson, Ian Tomlinson Hypermutant cancers frequently contain atypical driver gene variants, which may provide sub-optimal oncogenic advantages. The reason why wea...
by Jingyi Ke, Zi Wang, Zhengyang Guo, Guangshuo Ou, Wei Li Oncogenic BRAFV600E mutations drive constitutive MAPK signaling across various cancers; however, resistance to MEK inhib...
by Jake Colautti, Alexander C. Anderson, Wyatt P. K. Clark, Lindsey S. Marmont Bacterial cell division requires precise regulation of septal peptidoglycan (PG) synthesis by the es...
New research shows carboplatin drives the expansion of TP53-mutant blood clones far more strongly than PARP inhibitors, while inherited homologous recombination deficiency unexpect...
by Achille V. C. Manirakiza, Shakuntala Baichoo, Annette Uwineza, Damas Dukundane, Eulade Rugengamanzi, Janviere Mutamuliza, Allison M. O. Niragira, Raissa Muvunyi, Jeffrey Besada,...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.